|
US5770617A
(en)
*
|
1996-03-20 |
1998-06-23 |
Rutgers, The State University Of New Jersey |
Terbenzimidazoles useful as antifungal agents
|
|
US5935982A
(en)
*
|
1997-02-28 |
1999-08-10 |
The University Of North Carolina At Chapel Hill |
Methods of treating retroviral infection and compounds useful therefor
|
|
US6635668B1
(en)
*
|
1998-07-22 |
2003-10-21 |
The University Of North Carolina At Chapel Hill |
Imidazoline receptor binding compounds
|
|
JP2002524503A
(ja)
|
1998-09-17 |
2002-08-06 |
ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル |
二陽イオン分子の抗真菌活性
|
|
EP1685836A3
(en)
*
|
1998-09-17 |
2007-05-09 |
University Of North Carolina At Chapel Hill |
Antifungal activity of dicationic molecules
|
|
DE60042921D1
(de)
*
|
1999-03-29 |
2009-10-22 |
Shire Canada Inc |
Verwendung von cytidinderivaten zur behandlung von leukämie
|
|
DK1231910T3
(da)
*
|
1999-11-16 |
2009-08-31 |
Oncozyme Pharma Inc |
Pentamidin til behandling af cancer
|
|
US7115665B1
(en)
|
2000-11-16 |
2006-10-03 |
Onocozyme Pharma, Inc. |
Inhibitors of endo-exonuclease activity for treating cancer
|
|
US7156809B2
(en)
|
1999-12-17 |
2007-01-02 |
Q-Tec Systems Llc |
Method and apparatus for health and disease management combining patient data monitoring with wireless internet connectivity
|
|
US6677377B2
(en)
*
|
2000-06-21 |
2004-01-13 |
Georgetown University School Of Medicine |
Structure based discovery of inhibitors of matriptase for the treatment of cancer and other conditions
|
|
US6569853B1
(en)
*
|
2000-11-06 |
2003-05-27 |
Combinatorx, Incorporated |
Combinations of chlorpromazine and pentamidine for the treatment of neoplastic disorders
|
|
US6706754B2
(en)
*
|
2000-11-06 |
2004-03-16 |
The United States Of America As Represented By The Secretary Of The Army |
Reversed amidines and methods of using for treating, preventing, or inhibiting leishmaniasis
|
|
US20040006092A1
(en)
*
|
2001-08-31 |
2004-01-08 |
Neurochem, Inc. |
Amidine derivatives for treating amyloidosis
|
|
US6951880B2
(en)
|
2002-05-16 |
2005-10-04 |
Genelabs Technologies, Inc. |
Aryl and heteroaryl compounds as antibacterial and antifungal agents
|
|
AU2003245442B2
(en)
*
|
2002-06-13 |
2009-02-05 |
Vertex Pharmaceuticals Incorporated |
2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase IV inhibitors for the treatment of bacterial infections
|
|
US7569591B2
(en)
*
|
2003-01-31 |
2009-08-04 |
Vertex Pharmaceuticals Incorporated |
Gyrase inhibitors and uses thereof
|
|
US7618974B2
(en)
*
|
2003-01-31 |
2009-11-17 |
Vertex Pharmaceuticals Incorporated |
Gyrase inhibitors and uses thereof
|
|
US8193352B2
(en)
*
|
2003-01-31 |
2012-06-05 |
Vertex Pharmaceuticals Incorporated |
Gyrase inhibitors and uses thereof
|
|
US7582641B2
(en)
*
|
2003-01-31 |
2009-09-01 |
Vertex Pharmaceuticals Incorporated |
Gyrase inhibitors and uses thereof
|
|
AR042956A1
(es)
*
|
2003-01-31 |
2005-07-13 |
Vertex Pharma |
Inhibidores de girasa y usos de los mismos
|
|
US8404852B2
(en)
|
2003-01-31 |
2013-03-26 |
Vertex Pharmaceuticals Incorporated |
Gyrase inhibitors and uses thereof
|
|
US20050054708A1
(en)
*
|
2003-07-28 |
2005-03-10 |
Nichols Matthew James |
Combinations of drugs for the treatment of neoplasms
|
|
US20050080075A1
(en)
*
|
2003-08-25 |
2005-04-14 |
Nichols M. James |
Formulations, conjugates, and combinations of drugs for the treatment of neoplasms
|
|
US20050158320A1
(en)
*
|
2003-11-12 |
2005-07-21 |
Nichols M. J. |
Combinations for the treatment of proliferative diseases
|
|
US20050100508A1
(en)
*
|
2003-11-12 |
2005-05-12 |
Nichols M. J. |
Methods for identifying drug combinations for the treatment of proliferative diseases
|
|
US7262223B2
(en)
*
|
2004-01-23 |
2007-08-28 |
Neurochem (International) Limited |
Amidine derivatives for treating amyloidosis
|
|
US7967605B2
(en)
|
2004-03-16 |
2011-06-28 |
Guidance Endodontics, Llc |
Endodontic files and obturator devices and methods of manufacturing same
|
|
AU2005233632A1
(en)
|
2004-04-13 |
2005-10-27 |
Icagen, Inc. |
Polycyclic pyridines as potassium ion channel modulators
|
|
DE102004031656A1
(de)
*
|
2004-06-30 |
2006-01-19 |
Merck Patent Gmbh |
Tetrahydrochinoline
|
|
US7817792B2
(en)
*
|
2006-05-04 |
2010-10-19 |
Microsoft Corporation |
Hyperlink-based softphone call and management
|
|
DE102007013854A1
(de)
|
2007-03-20 |
2008-09-25 |
Merck Patent Gmbh |
Tetrahydrochinoline
|
|
DE102007013856A1
(de)
|
2007-03-20 |
2008-09-25 |
Merck Patent Gmbh |
Substituierte Tetrahydropyrrolochinoline
|
|
DE102007013855A1
(de)
|
2007-03-20 |
2008-09-25 |
Merck Patent Gmbh |
Substituierte Tetrahydrochinoline
|
|
EP2194981B1
(en)
*
|
2007-10-05 |
2011-11-23 |
Université de Mons-Hainaut |
Bisbenzimidazoles as antimalarial agents
|
|
WO2010132684A2
(en)
*
|
2009-05-13 |
2010-11-18 |
University Of Virginia Patent Foundation |
Inhibitors of inv(16) leukemia
|
|
JP6085829B2
(ja)
|
2011-01-14 |
2017-03-01 |
スペロ トリネム， インコーポレイテッド |
ピリミジンジャイレースおよびトポイソメラーゼｉｖ阻害剤
|
|
MX341342B
(es)
|
2011-01-14 |
2016-08-17 |
Vertex Pharma |
Formas solidas del inhibidor de girasa (r)-1-etil-3-[6-fluoro-5-[2 -(1-hidroxi-1-metil-etil) pirimidin-5-il]-7-(tetrahidrofuran-2-il) -1h-benzimidazol-2-il]urea.
|
|
US8481552B2
(en)
|
2011-01-14 |
2013-07-09 |
Vertex Pharmaceuticals Incorporated |
Solid forms of gyrase inhibitor (R)-1-ethyl-3-[5-[2-(1-hydroxy-1-methyl-ethyl)pyrimidin-5-YL]-7-(tetrahydrofuran-2-yl)-1H-benzimidazol-2-YL]urea
|
|
KR101882172B1
(ko)
|
2011-01-14 |
2018-07-26 |
스페로 트리넴, 인코포레이티드 |
자이라제 및 토포이소머라제 ⅳ 억제제의 제조방법
|
|
ES2576298T3
(es)
|
2011-06-20 |
2016-07-06 |
Vertex Pharmaceuticals Incorporated |
Ésteres de fosfato de inhibidores de girasa y topoisomerasa
|
|
US9018216B2
(en)
|
2012-07-18 |
2015-04-28 |
Vertex Pharmaceuticals Incorporated |
Solid forms of (R)-2-(5-(2-(3-ethylureido)-6-fluoro-7-(tetrahydrofuran-2-yl)-1H-benzo[d]imidazol-5-yl)pyrimidin-2-yl)propan-2-yl dihydrogen phosphate and salts thereof
|
|
US9572809B2
(en)
|
2012-07-18 |
2017-02-21 |
Spero Trinem, Inc. |
Combination therapy to treat Mycobacterium diseases
|
|
GB201506658D0
(en)
|
2015-04-20 |
2015-06-03 |
Cellcentric Ltd |
Pharmaceutical compounds
|
|
GB201506660D0
(en)
|
2015-04-20 |
2015-06-03 |
Cellcentric Ltd |
Pharmaceutical compounds
|
|
MX2017014613A
(es)
*
|
2015-05-15 |
2018-03-01 |
Gilead Sciences Inc |
Compuestos de bencimidazol e imadazopiridin-carboximidamida que tienen actividad como inhibidores de indolamina 2,3-dioxigenasa.
|
|
MX2019000179A
(es)
*
|
2016-07-27 |
2019-06-20 |
Univ Virginia Patent Foundation |
Combinacion de terapias para tratar el cancer.
|
|
US20200030295A1
(en)
*
|
2016-08-02 |
2020-01-30 |
Friedrich-Alexander-Universität Erlangen-Nürnberg |
Heterocyclic diamidines
|